These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 10737124)

  • 1. Adult-onset glycogen storage disease type II: phenotypic and allelic heterogeneity in German patients.
    Vorgerd M; Burwinkel B; Reichmann H; Malin JP; Kilimann MW
    Neurogenetics; 1998 Mar; 1(3):205-11. PubMed ID: 10737124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (-13T-->G) mutation in a majority of patients and a novel IVS10 (+1GT-->CT) mutation.
    Huie ML; Chen AS; Tsujino S; Shanske S; DiMauro S; Engel AG; Hirschhorn R
    Hum Mol Genet; 1994 Dec; 3(12):2231-6. PubMed ID: 7881425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a single base pair deletion (delta T525) and a C1634T missense mutation (pro545leu) on the expression of lysosomal alpha-glucosidase in patients with glycogen storage disease type II.
    Hermans MM; De Graaff E; Kroos MA; Mohkamsing S; Eussen BJ; Joosse M; Willemsen R; Kleijer WJ; Oostra BA; Reuser AJ
    Hum Mol Genet; 1994 Dec; 3(12):2213-8. PubMed ID: 7881422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a clinical assay for detection of GAA mutations and characterization of the GAA mutation spectrum in a Canadian cohort of individuals with glycogen storage disease, type II.
    McCready ME; Carson NL; Chakraborty P; Clarke JT; Callahan JW; Skomorowski MA; Chan AK; Bamforth F; Casey R; Rupar CA; Geraghty MT
    Mol Genet Metab; 2007 Dec; 92(4):325-35. PubMed ID: 17723315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant splicing at catalytic site as cause of infantile onset glycogen storage disease type II (GSDII): molecular identification of a novel IVS9 (+2GT-->GC) in combination with rare IVS10 (+1GT-->CT).
    Stroppiano M; Bonuccelli G; Corsolini F; Filocamo M
    Am J Med Genet; 2001 Jun; 101(1):55-8. PubMed ID: 11343339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen storage disease type II: identification of four novel missense mutations (D645N, G648S, R672W, R672Q) and two insertions/deletions in the acid alpha-glucosidase locus of patients of differing phenotype.
    Huie ML; Tsujino S; Sklower Brooks S; Engel A; Elias E; Bonthron DT; Bessley C; Shanske S; DiMauro S; Goto YI; Hirschhorn R
    Biochem Biophys Res Commun; 1998 Mar; 244(3):921-7. PubMed ID: 9535769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen-storage disease type II (acid maltase deficiency): identification of a novel small deletion (delCC482+483) in French patients.
    Nicolino M; Puech JP; Letourneur F; Fardeau M; Kahn A; Poenaru L
    Biochem Biophys Res Commun; 1997 Jun; 235(1):138-41. PubMed ID: 9196050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of eight novel mutations of the acid alpha-glucosidase gene causing the infantile or juvenile form of glycogen storage disease type II.
    Wan L; Lee CC; Hsu CM; Hwu WL; Yang CC; Tsai CH; Tsai FJ
    J Neurol; 2008 Jun; 255(6):831-8. PubMed ID: 18458862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late-onset GSDII with novel GAA gene mutation.
    Angelini C; Nascimbeni AC
    Clin Genet; 2007 Apr; 71(4):374-5. PubMed ID: 17470141
    [No Abstract]   [Full Text] [Related]  

  • 10. A de novo 13 nt deletion, a newly identified C647W missense mutation and a deletion of exon 18 in infantile onset glycogen storage disease type II (GSDII).
    Huie ML; Chen AS; Brooks SS; Grix A; Hirschhorn R
    Hum Mol Genet; 1994 Jul; 3(7):1081-7. PubMed ID: 7981676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation profile of the GAA gene in 40 Italian patients with late onset glycogen storage disease type II.
    Montalvo AL; Bembi B; Donnarumma M; Filocamo M; Parenti G; Rossi M; Merlini L; Buratti E; De Filippi P; Dardis A; Stroppiano M; Ciana G; Pittis MG
    Hum Mutat; 2006 Oct; 27(10):999-1006. PubMed ID: 16917947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetics of late onset glycogen storage disease II in Italy.
    Pittis MG; Filocamo M
    Acta Myol; 2007 Jul; 26(1):67-71. PubMed ID: 17915575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen storage disease type II: identification of a dinucleotide deletion and a common missense mutation in the lysosomal alpha-glucosidase gene.
    Kroos MA; van Leenen D; Verbiest J; Reuser AJ; Hermans MM
    Clin Genet; 1998 May; 53(5):379-82. PubMed ID: 9660056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended phenotype description and new molecular findings in late onset glycogen storage disease type II: a northern Italy population study and review of the literature.
    Remiche G; Ronchi D; Magri F; Lamperti C; Bordoni A; Moggio M; Bresolin N; Comi GP
    J Neurol; 2014 Jan; 261(1):83-97. PubMed ID: 24158270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The conservative substitution Asp-645-->Glu in lysosomal alpha-glucosidase affects transport and phosphorylation of the enzyme in an adult patient with glycogen-storage disease type II.
    Hermans MM; de Graaff E; Kroos MA; Wisselaar HA; Willemsen R; Oostra BA; Reuser AJ
    Biochem J; 1993 Feb; 289 ( Pt 3)(Pt 3):687-93. PubMed ID: 8094613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diagnosis of German patients with late-onset glycogen storage disease type II.
    Joshi PR; Gläser D; Schmidt S; Vorgerd M; Winterholler M; Eger K; Zierz S; Deschauer M
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S261-5. PubMed ID: 18607768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silent exonic mutation in the acid-alpha-glycosidase gene that causes glycogen storage disease type II by affecting mRNA splicing.
    Maimaiti M; Takahashi S; Okajima K; Suzuki N; Ohinata J; Araki A; Tanaka H; Mukai T; Fujieda K
    J Hum Genet; 2009 Aug; 54(8):493-6. PubMed ID: 19609281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical features and acid alpha-glucosidase gene mutation in 7 Chinese patients with glycogen storage disease type II].
    Liu Q; Zhao J; Wang ZX; Zhang W; Yuan Y
    Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(25):1981-5. PubMed ID: 24169249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the functional impact on the pre-mRNA splicing process of 28 nucleotide variants associated with Pompe disease in GAA exon 2 and their recovery using antisense technology.
    Goina E; Musco L; Dardis A; Buratti E
    Hum Mutat; 2019 Nov; 40(11):2121-2130. PubMed ID: 31301153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of six novel mutations in the acid alpha-glucosidase gene in three Spanish patients with infantile onset glycogen storage disease type II (Pompe disease).
    Fernandez-Hojas R; Huie ML; Navarro C; Dominguez C; Roig M; Lopez-Coronas D; Teijeira S; Anyane-Yeboa K; Hirschhorn R
    Neuromuscul Disord; 2002 Feb; 12(2):159-66. PubMed ID: 11738358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.